1. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats;Fujiwara;Diabetes,1988
2. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers;Hofmann;Diabetes Care,1992
3. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone;Hofmann;Endocrinology,1991
4. A new oral hypoglycemic agent, 5-[4-[2-(5-ethyl-2-pyrudul)ethoxyl]benzyl] 2,4-thiazolidinedione (AD-4833, U-72, 107E, pioglitazone): I. Effects on glucose and lipid metabolism in normal and insulin resistant animals;Ikeda;Arzneim. Forsch. Drug Res.,1990
5. Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs;Kawai;Arzneim. Forsch. Drug Res.,1997